Lung Cancer Clinical Trial
Official title:
Palliative Care for Quality of Life and Symptom Concerns in Early Stage Lung Cancer
RATIONALE: Palliative care may be more effective than standard care in improving quality of
life and symptoms in patients with lung cancer.
PURPOSE: This clinical trial is studying the effects of palliative care on quality of life
and symptom control in patients with stage I, stage II, or stage IIIA non-small cell lung
cancer that can be removed by surgery.
OBJECTIVES:
- To compare the effects of palliative care intervention (PCI) vs standard care on
overall quality of life and psychological distress in patients with resectable stage
I-IIIA non-small cell lung cancer.
- To compare symptom control in these patients.
- To compare geriatric assessment outcomes, as measured by OARS (Older Americans
Resources and Services) Instrumental Activities of Daily Living, MOS Activities of
Daily Living, MOS (Medical Outcomes Study)Social Activities Limitation Scale, Hospital
Anxiety and Depression Scale scores, and Karnofsky performance scale, in these
patients.
- To compare the effects of the PCI vs standard care on resource use.
- To identify subgroups of patients who benefit most from the PCI in relation to
sociodemographic characteristics, treatment factors, and geriatric assessment
predictors at week 12.
OUTLINE: Patients assigned to 1 of 2 groups.
- Group I (standard care): Patients receive standard care. Patients complete
questionnaires at baseline and at 6, 12, 24, 36, and 52 weeks to evaluate quality of
life (QOL), symptoms, psychological distress, and geriatric assessments. A medical
chart review is performed at 52 weeks to assess the progression of treatment, episodes
of care, and re-admissions.
- Group II (palliative care intervention): Patients receive an individualized
interdisciplinary palliative care intervention combining patient-centered teaching
principles and concepts that are learner-centered (builds on the strengths, interests,
and needs of the learner), knowledge-centered (teacher is proficient in the content
being taught), assessment-centered (learners are given an opportunity to test their
understanding and receive feedback), and community-centered (opportunities are
available for continued learning and support). Patients undergo 4 teaching sessions
(based on the patient-centered teaching principles and concepts) that focus on
physical, psychological, social, and spiritual well-being, respectively, once a week in
weeks 3-6. Patients then receive 4 follow-up phone calls in weeks 9-21 to clarify
questions or review concerns from the teaching sessions and to coordinate follow-up
resources as needed. Patients also complete questionnaires as in group I.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
| Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
| Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
| Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
| Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
| Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
| Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
| Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
| Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|